BioMed Research International / 2015 / Article / Fig 2

Clinical Study

Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic Targets

Figure 2

Nine microRNAs had higher expressed levels in AS group than healthy control group, and the expression levels of them downregulated after regular etanercept therapy for 12 weeks. The calibrated signal ratio of AS group before therapy to healthy control group were >3 : 1, and the ratio of AS group after therapy to before therapy were <1 : 3. HC, healthy control; AS, ankylosing spondylitis.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.